SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-16-092637
Filing Date
2016-04-04
Accepted
2016-04-04 18:19:18
Documents
2
Period of Report
2016-03-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v436158_3.html 3  
1 OWNERSHIP DOCUMENT v436158_3.xml 3 1594
2 POWER OF ATTORNEY v436158_ex24.htm EX-24 5791
  Complete submission text file 0001144204-16-092637.txt   8908
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS, INC. 605 THIRD AVENUE, 34TH FLOOR NEW YORK NY 10158
Business Address
Fiorino Anthony S. (Reporting) CIK: 0001608901 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35076 | Film No.: 161552392